Several factors can increase PD-L1 expression in MDSCs, such as HIF1α activation (Wagner Grau 2011), tumor-derived exosomes (Burga et al. 2015; Iwata et al. 2016), and metabolic changes (Prima et al. 2017). Here, CD274 is linked to neoplasm.